4.6 Review

Immunonutrition and prehabilitation in pancreatic cancer surgery: A new concept in the era of ERAS? and neoadjuvant treatment

Related references

Note: Only part of the references are listed.
Article Oncology

Neoadjuvant therapy or upfront surgery for resectable and borderline resectable pancreatic cancer: A meta-analysis of randomised controlled trials

Jacob L. van Dam et al.

Summary: This study found that neoadjuvant therapy can improve overall survival in patients with borderline resectable pancreatic cancer. However, more evidence is needed to determine whether it also improves survival in patients with resectable pancreatic cancer.

EUROPEAN JOURNAL OF CANCER (2022)

Article Oncology

Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial

Eva Versteijne et al.

Summary: This study investigates the impact of neoadjuvant chemoradiotherapy on the survival of patients with resectable and borderline resectable pancreatic cancer. The results demonstrate that neoadjuvant chemoradiotherapy improves overall survival compared to upfront surgery in these patients.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Review Oncology

Expert opinion on management of pancreatic exocrine insufficiency in pancreatic cancer

G. Roeyen et al.

Summary: Pancreatic exocrine insufficiency (PEI) is a common condition in patients with pancreatic cancer (PC). PERT treatment is widely used, but there is limited clinical evidence supporting its effectiveness. More research is needed to evaluate the efficacy of PERT in PC patients.

ESMO OPEN (2022)

Article Oncology

Diversified Effects of Bile Contamination, Postoperative Infections, and Antimicrobial Resistance Level on the Oncologic Prognosis After Pancreatoduodenectomy for Ductal Adenocarcinoma

Luca Gianotti et al.

Summary: This study investigates the association between bile contamination, postoperative infections, and multi-level drug resistance with the long-term prognosis of patients undergoing pancreatic cancer surgery. The results show that postoperative multi-level drug resistant infections are a significant risk factor for poor overall survival after pancreatoduodenectomy for ductal adenocarcinoma.

ANTICANCER RESEARCH (2022)

Article Nutrition & Dietetics

Effect of immunonutrition on infectious complications in low skeletal muscle mass patients after pancreaticoduodenectomy

Arata Furukawa et al.

Summary: This study revealed that preoperative immunonutrition can reduce the incidence of postoperative infectious complications in low skeletal muscle mass patients undergoing pancreaticoduodenectomy (PD).

CLINICAL NUTRITION (2021)

Review Gastroenterology & Hepatology

Paradigm shift in gastrointestinal surgery - combating sarcopenia with prehabilitation: Multimodal review of clinical and scientific data

Frederick H. Koh et al.

Summary: The importance of sarcopenia in surgical patients has been increasingly recognized, with evidence showing its significance as an independent predictor of postoperative complications and outcomes. Prehabilitation, as a concept to optimize health before surgery, has shown promising initial results in improving patient outcomes.

WORLD JOURNAL OF GASTROINTESTINAL SURGERY (2021)

Review Gastroenterology & Hepatology

Neoadjuvant treatment: A window of opportunity for nutritional prehabilitation in patients with pancreatic ductal adenocarcinoma

Ilaria Trestini et al.

Summary: PDAC patients often present with advanced disease at diagnosis, with NAT becoming the standard of care but increasing the risk of nutritional decline. Data on prehabilitation in NAT patients are scarce, and nutritional management and prehabilitation programs may have important implications for PDAC patient outcomes.

WORLD JOURNAL OF GASTROINTESTINAL SURGERY (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Review Nutrition & Dietetics

Clinical Implications of Malnutrition in the Management of Patients with Pancreatic Cancer: Introducing the Concept of the Nutritional Oncology Board

Giulia Rovesti et al.

Summary: Pancreatic cancer patients often experience malnutrition, leading to cancer cachexia and sarcopenic obesity which significantly impact the prognosis of the disease. However, the importance of these nutritional imbalances is often overlooked in clinical practice, with detrimental effects on patient outcomes.

NUTRIENTS (2021)

Review Nutrition & Dietetics

Optimal Perioperative Nutrition Therapy for Patients Undergoing Pancreaticoduodenectomy: A Systematic Review with a Component Network Meta-Analysis

Shang-Yu Wang et al.

Summary: The systematic review summarized that preoperative enteral feeding combined with postoperative enteral nutrition, preoperative immunonutrient supplement, and preoperative oral immunonutrient supplement combined with postoperative immunonutrients are associated with a decrease in infectious complications. Postoperative total parenteral nutrition and preoperative oral immunonutrient supplement combined with postoperative immunonutrients were found to be clinically beneficial for the prevention of postoperative pancreatic fistula.

NUTRIENTS (2021)

Article Nutrition & Dietetics

ESPEN practical guideline: Clinical Nutrition in cancer

Maurizio Muscaritoli et al.

Summary: This practical guideline is based on the current scientific ESPEN guidelines on nutrition in cancer patients, providing 43 recommendations for the nutritional and metabolic management of patients with neoplastic diseases. It offers guidance to health care providers involved in the management of cancer patients to offer optimal nutritional care.

CLINICAL NUTRITION (2021)

Article Nutrition & Dietetics

ESPEN practical guideline: Clinical nutrition in surgery

Arved Weimann et al.

Summary: Early oral feeding is essential for surgical patients to prevent underfeeding and reduce the risk of postoperative complications. Nutritional management, including avoiding prolonged fasting, early initiation of oral feeding, and immediate nutritional therapy for at-risk patients, is crucial for successful perioperative care.

CLINICAL NUTRITION (2021)

Review Oncology

Is enhancing recovery after pancreatic cancer surgery even possible?

Monish Karunakaran et al.

Summary: Despite low compliance, ERAS pathways have been successful in achieving their intended outcomes of reducing length of stay, hospital readmissions, morbidity, and mortality following pancreatic surgery. Supplementing existing ERAS pathways with prehabilitation measures, risk-stratified clinical pathways, and access to step-down care facilities post-discharge may facilitate broader utilization.

CHINESE CLINICAL ONCOLOGY (2021)

Article Nutrition & Dietetics

Nutritional status and functional status of the pancreatic cancer patients and the impact of adjacent symptoms

I Santos et al.

Summary: Pancreatic cancer patients often exhibit severe weight loss and anorexia symptoms, leading to deterioration of nutritional status and functional status, indicating a high nutritional risk population.

CLINICAL NUTRITION (2021)

Review Oncology

Postoperative morbidity following pancreatic cancer surgery is significantly associated with worse overall patient survival; systematic review and meta-analysis

Ioannis Mintziras et al.

Summary: Postoperative complications after potentially curative resection of PDAC are significantly associated with worse overall patient survival, with the hazard of death 1.5 times higher in patients experiencing severe complications compared to those without severe complications. Meta-analysis demonstrates a reduced overall survival following any complication.

SURGICAL ONCOLOGY-OXFORD (2021)

Review Nutrition & Dietetics

Oral Nutritional Supplements and Enteral Nutrition in Patients with Gastrointestinal Surgery

Maria Wobith et al.

Summary: Patients undergoing gastrointestinal surgery are following enhanced recovery after surgery (ERAS) protocols, where oral feeding is emphasized and malnutrition is common. It is important to identify patients at metabolic risk early and monitor their nutritional status postoperatively, especially after surgery in the upper gastrointestinal tract. The article provides an overview of perioperative enteral nutrition concepts in these patients.

NUTRIENTS (2021)

Article Oncology

Pancreatic Adenocarcinoma, Version 2.2021

Margaret A. Tempero et al.

Summary: Pancreatic cancer is the fourth leading cause of cancer-related death in the United States, with a major challenge being advanced disease at diagnosis. While survival rates have not significantly changed, newer treatments, including targeted therapies, offer hope for patients. The manuscript focuses on systemic therapy approaches for locally advanced and metastatic disease.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)

Article Gastroenterology & Hepatology

Effects of Pancreatic Enzyme Replacement Therapy on Body Weight and Nutritional Assessments After Pancreatoduodenectomy in a Randomized Trial

Hongbeom Kim et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)

Letter Oncology

Nutritional support in pancreatic cancer

Riccardo Caccialanza et al.

CANCER (2020)

Review Oncology

Pancreatic Enzyme Replacement Therapy in Pancreatic Cancer

Raffaele Pezzilli et al.

CANCERS (2020)

Review Oncology

Neoadjuvant Treatment in Pancreatic Cancer

Atsushi Oba et al.

FRONTIERS IN ONCOLOGY (2020)

Article Gastroenterology & Hepatology

Global Burden of 5 Major Types of Gastrointestinal Cancer

Melina Arnold et al.

GASTROENTEROLOGY (2020)

Review Gastroenterology & Hepatology

Prehabilitation prior to surgery for pancreatic cancer: A systematic review

James R. Bundred et al.

PANCREATOLOGY (2020)

Review Nutrition & Dietetics

The Role of Immunonutrition in Patients Undergoing Pancreaticoduodenectomy

Beata Jablonska et al.

NUTRIENTS (2020)

Article Gastroenterology & Hepatology

Major Complications Independently Increase Long-Term Mortality After Pancreatoduodenectomy for Cancer

M. Sandini et al.

JOURNAL OF GASTROINTESTINAL SURGERY (2019)

Article Gastroenterology & Hepatology

Characterising the impact of body composition change during neoadjuvant chemotherapy for pancreatic cancer

Oonagh M. Griffin et al.

PANCREATOLOGY (2019)

Review Health Care Sciences & Services

Sarcopenia: looking to muscle mass to better manage pancreatic cancer patients

Debora Basile et al.

CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE (2019)

Article Gastroenterology & Hepatology

Anthropometric Changes in Patients with Pancreatic Cancer Undergoing Preoperative Therapy and Pancreatoduodenectomy

Jordan M. Cloyd et al.

JOURNAL OF GASTROINTESTINAL SURGERY (2018)

Article Gastroenterology & Hepatology

Impact of enhanced recovery after surgery programs on pancreatic surgery: A meta-analysis

Hai-Bin Ji et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2018)

Review Nutrition & Dietetics

Nutritional and Metabolic Derangements in Pancreatic Cancer and Pancreatic Resection

Taylor M. Gilliland et al.

NUTRIENTS (2017)

Article Nutrition & Dietetics

ESPEN guidelines on nutrition in cancer patients

Jann Arends et al.

CLINICAL NUTRITION (2017)

Article Medicine, General & Internal

Early combined parenteral and enteral nutrition for pancreaticoduodenectomy - Retrospective cohort analysis

Pascal Probst et al.

ANNALS OF MEDICINE AND SURGERY (2016)

Article Nutrition & Dietetics

Prevalence of Malnutrition and Current Use of Nutrition Support in Patients With Cancer

Xavier Hebuterne et al.

JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2014)

Article Oncology

Cachexia in Patients with Chronic Pancreatitis and Pancreatic Cancer: Impact on Survival and Outcome

Jeannine Bachmann et al.

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2013)

Article Nutrition & Dietetics

Nutrition Screening Tools: An Analysis of the Evidence

Annalynn Skipper et al.

JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2012)

Review Medicine, General & Internal

Pancreatic Cancer

Manuel Hidalgo

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Gastroenterology & Hepatology

Cachexia worsens prognosis in patients with resectable pancreatic cancer

Jeannine Bachmann et al.

JOURNAL OF GASTROINTESTINAL SURGERY (2008)